Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 72.0 | 76 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 76.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 76.0 | 62 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 65.5 | 74 | |
RA2159 | EO1428 | 1.0 | uM | 3 | MIP-1B | 58.0 | 65 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | MIP-1B | 87.0 | 83 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 73.0 | 52 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 80.5 | 70 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 64.0 | 76 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 61.0 | 73 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 74.0 | 65 | |
N2586 | EO1428 | 1.0 | uM | 3 | MIP-1B | 59.0 | 81 | ||||
0 | MIP-1B | 57.5 | 62 | ||||||||
RA2159 | 3 | MIP-1B | 58.0 | 74 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | MIP-1B | 60.0 | 63 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | MIP-1B | 56.0 | 63 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | MIP-1B | 58.0 | 55 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 65.0 | 43 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | MIP-1B | 56.0 | 73 | ||||
RA2159 | 3 | MIP-1B | 61.5 | 64 | |||||||
N2586 | 3 | MIP-1B | 59.5 | 58 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | MIP-1B | 56.0 | 77 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | MIP-1B | 62.0 | 67 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | MIP-1B | 59.0 | 39 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 58.5 | 42 |